Drug Shortage Report for SANDOZ MOXIFLOXACIN
Report ID | 221835 |
Drug Identification Number | 02411520 |
Brand name | SANDOZ MOXIFLOXACIN |
Common or Proper name | MOXIFLOXACIN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | MOXIFLOXACIN |
Strength(s) | 0.5% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 3 ML LDP |
ATC code | S01AE |
ATC description | ANTIINFECTIVES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2024-03-11 |
Estimated end date | 2024-03-15 |
Actual end date | 2024-04-03 |
Shortage status | Resolved |
Updated date | 2024-04-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-04-04 | English | Compare |
v5 | 2024-04-03 | French | Compare |
v4 | 2024-04-03 | English | Compare |
v3 | 2024-03-12 | English | Compare |
v2 | 2024-03-11 | French | Compare |
v1 | 2024-03-11 | English | Compare |
Showing 1 to 6 of 6